Atlas Trials

A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

Clinical trial NCT02469467 · UNKNOWN

Trial details

NCT number
NCT02469467
Sponsor
KDL Inc.
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
End Stage Renal DiseaseHyperphosphatemia
Start date
2015-06-01
Primary completion
2016-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.